Efficacy and safety of fluconazole prophylaxis in extremely low birth weight infants: multicenter pre-post cohort study

Table 2 Details of invasive fungal infection events

Patient	Organism	Fluconazole-resistance	Onset day	Site of Infection	Mortality	Cause of Death
During the pre-prophylaxis period
1	Candida albicans	Sensitive	8, 39	Blood	Died	Invasive fungal infection
2	Candida parapsilosis	Sensitive	18	Blood	Alive
3	Candida parapsilosis	Sensitive	7	Blood	Alive
4	Candida parapsilosis	Sensitive	13	Blood	Alive
5	Candida glabrata	Resistant	13	Blood	Died	Invasive fungal infection
6	Candida glabrata	Sensitive	11	Blood	Alive
7	Candida albicans	Sensitive	8	Blood, urine	Died	Invasive fungal infection
During the fluconazole prophylaxis period
8	Candida parapsilosis	Sensitive	32	Blood, urine	Alive
9	Candida glabrata	Resistant	19	Blood	Died	Invasive fungal infection
10	Candida parapsilosis	Resistant	24	Blood, ascites	Died	Cardiac failure, NEC^a
11	Candida parapsilosis	Resistant	28	Blood	Died	Unknown
12	Candida glabrata	Sensitive	8	Blood	Alive
13	Candida parapsilosis	Sensitive	21	Blood	Alive
14	Candida parapsilosis	Sensitive	6	Blood	Alive
15	Candida albicans	Sensitive	21	Blood, urine	Alive
16	Candida parapsilosis	Resistant	43, 71	Blood	Alive
17	Candida parapsilosis	Resistant	11	Blood	Alive
18	Candida parapsilosis	Resistant	17	Blood	Alive
19	Candida parapsilosis	Sensitive	12	Blood	Alive

ISSN: 1471-2431